Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythroid Precursor Cells | 1 | 2013 | 1 | 0.400 |
Why?
|
| Apoferritins | 1 | 2013 | 4 | 0.390 |
Why?
|
| Macrophages | 1 | 2013 | 207 | 0.350 |
Why?
|
| Histiocytosis, Sinus | 1 | 2011 | 3 | 0.340 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2011 | 3 | 0.340 |
Why?
|
| Lymph Nodes | 1 | 2011 | 113 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 9 | 3 | 2005 | 16 | 0.280 |
Why?
|
| Skin Neoplasms | 2 | 2012 | 220 | 0.260 |
Why?
|
| Loss of Heterozygosity | 1 | 2005 | 20 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2005 | 37 | 0.220 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2015 | 18 | 0.210 |
Why?
|
| Melanoma | 1 | 2005 | 166 | 0.200 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2010 | 25 | 0.200 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 762 | 0.140 |
Why?
|
| Lymphoma | 2 | 2013 | 37 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2015 | 28 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 90 | 0.110 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2013 | 7 | 0.100 |
Why?
|
| Pseudolymphoma | 1 | 2013 | 5 | 0.100 |
Why?
|
| Translocation, Genetic | 2 | 2004 | 20 | 0.100 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2013 | 1 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 545 | 0.100 |
Why?
|
| Homeostasis | 1 | 2013 | 130 | 0.090 |
Why?
|
| Iron | 1 | 2013 | 94 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 114 | 0.090 |
Why?
|
| Humans | 13 | 2015 | 32284 | 0.090 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2012 | 6 | 0.090 |
Why?
|
| Mycosis Fungoides | 1 | 2012 | 12 | 0.090 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 53 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2012 | 50 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 245 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 408 | 0.080 |
Why?
|
| Hodgkin Disease | 1 | 2010 | 16 | 0.080 |
Why?
|
| DNA, Neoplasm | 3 | 2005 | 52 | 0.080 |
Why?
|
| Female | 9 | 2015 | 19947 | 0.080 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 28 | 0.080 |
Why?
|
| Graft vs Host Disease | 1 | 2010 | 39 | 0.080 |
Why?
|
| Aged | 7 | 2015 | 10265 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 637 | 0.070 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 79 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 47 | 0.070 |
Why?
|
| Copper | 1 | 2007 | 11 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2012 | 140 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 186 | 0.060 |
Why?
|
| Sarcoma, Synovial | 1 | 2006 | 6 | 0.060 |
Why?
|
| Ganglion Cysts | 1 | 2006 | 8 | 0.060 |
Why?
|
| Middle Aged | 7 | 2015 | 11853 | 0.060 |
Why?
|
| Male | 9 | 2015 | 19443 | 0.060 |
Why?
|
| Microdissection | 1 | 2005 | 2 | 0.060 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 50 | 0.050 |
Why?
|
| Anemia, Refractory | 1 | 2004 | 2 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 104 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2004 | 26 | 0.050 |
Why?
|
| Adult | 5 | 2015 | 9259 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2011 | 3416 | 0.050 |
Why?
|
| Histiocytes | 1 | 2002 | 3 | 0.050 |
Why?
|
| Germinal Center | 1 | 2002 | 6 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2002 | 6 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 12 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2002 | 18 | 0.050 |
Why?
|
| Angiolymphoid Hyperplasia with Eosinophilia | 1 | 2002 | 3 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2002 | 11 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2002 | 19 | 0.050 |
Why?
|
| Adolescent | 2 | 2015 | 3519 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 24 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2006 | 43 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 3902 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 12 | 0.020 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2012 | 10 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2012 | 31 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2012 | 65 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 504 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 1534 | 0.020 |
Why?
|
| Immune System Diseases | 1 | 2010 | 1 | 0.020 |
Why?
|
| Biological Therapy | 1 | 2010 | 18 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 66 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2010 | 100 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 158 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2010 | 68 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 105 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2010 | 3628 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 2649 | 0.020 |
Why?
|
| Child | 2 | 2006 | 2435 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2010 | 221 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2012 | 490 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2007 | 25 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2007 | 45 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 1241 | 0.020 |
Why?
|
| Neutrophils | 1 | 2007 | 120 | 0.020 |
Why?
|
| Foot | 1 | 2006 | 40 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2006 | 62 | 0.020 |
Why?
|
| Radiography | 1 | 2006 | 363 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2004 | 20 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 253 | 0.010 |
Why?
|
| Reed-Sternberg Cells | 1 | 2002 | 1 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Philadelphia Chromosome | 1 | 2002 | 4 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2002 | 9 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 33 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2002 | 47 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 38 | 0.010 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2002 | 101 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 83 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 95 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 246 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2002 | 94 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 149 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 183 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 1224 | 0.010 |
Why?
|